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Chronic rhinosinusitis with 
nasal polyps is characterized 
by dysbacteriosis of the nasal 
microbiota
Thanit Chalermwatanachai  1,2, Ramiro Vilchez-Vargas3, Gabriele Holtappels1, Tim Lacoere3, 
Ruy Jáuregui4, Frederiek-Maarten Kerckhof  3, Dietmar H. Pieper4, Tom Van de Wiele3, Mario 
Vaneechoutte5, Thibaut Van Zele1 & Claus Bachert1,6
Chronic rhinosinusitis with nasal polyp (CRSwNP) patients are often characterized by asthma 
comorbidity and a type-2 inflammation of the sinonasal mucosa. The mucosal microbiota has been 
suggested to be implicated in the persistence of inflammation, but associations have not been well 
defined. To compare the bacterial communities of healthy subjects with CRSwNP patients, we collected 
nasal swabs from 17 healthy subjects, 21 CRSwNP patients without asthma (CRSwNP−A), and 20 
CRSwNP patients with co-morbid asthma (CRSwNP+A). We analysed the microbiota using high-
throughput sequencing of the bacterial 16S rRNA. Bacterial communities were different between the 
three groups. Haemophilus influenzae was significantly enriched in CRSwNP patients, Propionibacterium 
acnes in the healthy group; Staphylococcus aureus was abundant in the CRSwNP−A group, even 
though present in 57% of patients. Escherichia coli was found in high amounts in CRSwNP+A patients. 
Nasal tissues of CRSwNP+A patients expressed significantly higher concentrations of IgE, SE-IgE, and 
IL-5 compared to those of CRSwNP−A patients. Co-cultivation demonstrated that P. acnes growth was 
inhibited by H. influenzae, E. coli and S. aureus. The nasal microbiota of healthy subjects are different 
from those of CRSwNP−A and CRSwNP+A patients. However, the most abundant species in healthy 
status could not inhibit those in CRSwNP disease.
Chronic rhinosinusitis with nasal polyps (CRSwNP) is defined as a subgroup of chronic rhinosinusitis (CRS) that 
is characterized by the presence of fleshy swellings (nasal polyps) that develop in the lining of the nose and para-
nasal sinuses1. Nasal polyps (NP) are believed to arise in the nasal mucosa because of chronic inflammation. In 
central Europe, CRSwNP is mostly characterized by a moderate to severe T helper type 2 (Th2)-mediated inflam-
mation with hypereosinophilia and increased IgE concentrations. CRSwNP is difficult to treat and recurrences 
are frequent, despite medical treatment and surgical interventions. In addition, patients suffering from CRSwNP 
often have comorbid diseases, such as asthma and aspirin intolerance2,3.
The definitive mechanisms underlying the pathogenesis of CRS remain poorly elucidated4. Microbial involve-
ment have been considered to be one of the mechanisms contributing to the inflammation in case of CRS5,6. 
Whereas in some reports the characteristics of sinus microbiota in CRS were similar to those of control groups7–9, 
other analyses, making use of CRS phenotypes or endotypes, demonstrated different compositions of resident 
sinus bacterial communities6,10. Our group has previously demonstrated that Staphylococcus aureus is able to 
drive Th2 type inflammation and that it is associated with Th2-biased CRSwNP5,6,11. We have also reported that 
the expression of IL-5 and of IgE against S. aureus superantigens (SE-IgE) within polyp tissue is associated with 
comorbid asthma12,13. Furthermore, because the levels of IL-5 and SE-IgE were significantly increased in recurrent 
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versus non-recurrent CRSwNP14 and because several studies suggest that alterations in the airway microbiota 
may be associated with inflammatory processes6,7,10,15–17. We reasoned that a study with well-defined subgroups 
of CRS patients could possibly identify different microbiota, which might be related to specific pathological or 
immunological characteristics of the inflammation.
Here, we hypothesized that heterogeneousness of CRSwNP with regard to asthma comorbidity could be asso-
ciated with the presence of compositionally distinct sinus microbiota which affect host immune responses. To 
validate this hypothesis, we collected nasal swabs to obtain a suitable biological sample from the middle meatus, 
the common location of nasal polyps18, of CRSwNP patients without co-morbid asthma and compared their 
sinus microbiota to that of patients with CRSwNP with co-morbid asthma and to that of healthy control subjects, 
using 16S ribosomal RNA-gene (16S rRNA gene) high throughput sequencing. Furthermore, we studied the in 
vitro inhibitory and/or stimulatory effects of isolated strains of different species on each other, specifically to 
understand to what extent the species that are most frequently present in controls may protect the mucosa against 
germs most frequent in patients with CRSwNP.
Materials and Methods
Study Design and Population. We evaluated nasal microbiota from non-asthmatic CRSwNP patients, 
CRSwNP patients with co-morbid asthma, and healthy control subjects. Diagnosis of CRSwNP was made accord-
ing to the European Position Paper on Rhinosinusitis and Nasal Polyps19. Diagnosis of asthma was confirmed by 
a pulmonologist. The atopic status was evaluated by skin prick tests to common inhalant allergens. The control 
group consisted of healthy volunteers and patients who were free from rhinosinusitis, asthma, and atopy. Patients 
less than 18 years of age, subjects with cystic fibrosis, known or suspected immunodeficiency or autoimmune 
disease, and/or suspected of the use of systemic antibiotics or oral steroids in the last 3 months before sample 
collection, were excluded from this study.
Ethics statement. This study was approved by the ethics committee of the University of Ghent, Belgium and 
assigned number B670201422215. All participants provided written informed consent prior to their participation 
in the project. All experiments were performed in accordance with relevant guidelines and regulations.
Sample Collection. Specimens were collected at the Ghent University Hospital, Belgium. Swab specimens 
for DNA extraction were obtained with eSwab (COPAN, Brescia, Italy). Swabs were endoscopically guided to 
the middle meatus region and rotated at least 3 times. In addition, nasal tissue samples were obtained from the 
patients during endonasal sinus surgery. All samples were immediately transported to the laboratory and snap 
frozen in liquid nitrogen and stored at −80 °C until further analysis.
Measurement of Cytokines in Nasal Tissue Samples. Snap-frozen tissue specimens were weighed and 
suspended in a ratio 0.1 g of tissue per 1 mL of 0.9% NaCl solution with a complete protease inhibitor cocktail 
(Roche, Mannheim, Germany). To prepare soluble protein fractions, frozen tissues were mechanically pulverized 
using a Tissue Lyser LT (Qiagen, Hilden, Germany) at 50 oscillations per second for two minutes in prechilled 
Eppendorf tubes. Homogenized tissues were centrifuged at 1,800 × g for ten minutes at 4 °C, and the superna-
tants were collected. Total IgE, eosinophil cationic protein (ECP) and specific IgE to staphylococcal enterotox-
ins (SE-IgE) were measured using the UniCAP system (Thermo Fisher Scientific, Phadia, Uppsala, Sweden). 
Tumor necrosis factor-alpha (TNFα), interleukin (IL)-5 and IL-17 were quantified using the Bio-Plex 200 System 
(Bio-Rad, Temse, Belgium).
DNA Extraction and Bioinformatic Analysis. DNA was extracted from the whole swab using the 
FastDNA Spin kit (MP Biomedicals, Solon, Ohio) according to the manufacturer’s instructions. Total DNA con-
centration was measured with a NanoDrop ND-1000 spectrophotometer (Isogen Life Sciences, IJsselstein, The 
Netherlands). The quality of the extracted DNA was evaluated on a 1% agarose gel. Libraries were prepared as 
previously described20, using the primers 27F and 338R20 for the V1-V2 region of the 16S rRNA gene. Libraries 
were sequenced on a MiSeq (Illumina, Hayward, California). Each sequence was identified using the SILVA data-
base21. Definition of operational taxonomic units (OTUs) and data-set quality filter was performed as previously 
described20. After quality filtering, the dataset was then filtered to consider only those OTUs sequences that were 
present in at least one sample at a relative abundance of >0.1% or that were present in all samples at a relative 
abundance of >0.001%. All samples were randomly re-sampled to equal the smallest read size of 6,682 reads, 
using the PhyloSeq package22 from the free software R package for statistical computing and graphics23. All the 
reads were grouped into 942 sequences. All sequences were assigned a taxonomic affiliation (phylotype) based 
on the naive Bayesian classification (RDP classifier)24. A genus name was assigned to a sequences when only 16S 
rRNA gene fragments of previously described isolates belonging to that genus and of 16S rRNA gene fragments 
originating from uncultured representatives of that genus showed ≤2 mismatches. Species assignments were 
performed using the Basic Local Alignment Search Tool (BLAST). Assignation of a name demanded at least 99% 
sequence identity over 95% of sequence length25.
Statistical Analysis. Statistical analysis was performed using GraphPad Prism version 6.00 for Mac OS X 
(GraphPad Software, La Jolla, CA: www.graphpad.com). The categorical outcomes (presence/absence of con-
dition) were expressed as frequencies or percentages and were analyzed using the Chi-square test. The interval 
data (age, level of cytokines) were tested for distribution using the Shapiro-Wilk normality test. Assessment of 
the significance of intergroup correlation was performed using the parametric test for Gaussian distributed data 
and a non-parametric method for non-normally distributed data. The ecological profiles were analyzed using 
the PAST3 program26. All Principal Coordinate Analyses (PCoA) were based on a Bray-Curtis similarity index, 
which operated at the phylotype level. To test for community compositional differences, permutation multivariate 
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analysis of variance (PERMANOVA) was employed. Similarity Percentage (SIMPER) analysis was used to deter-
mine the contribution of each species to the observed dissimilarity between samples and to identify the species 
that are most important in creating the observed pattern. In each group, the 20 bacterial species with the highest 
relative abundance were selected. This resulted in 22 different bacterial species for further analyses. The difference 
of relative abundance was calculated using a nonparametric Kruskal-Wallis test and corrections of significance for 
between-group comparisons were calculated using Dunn’s test. The Spearman’s rank correlation was employed 
to assess the statistical correlation between cytokine and bacterial relative abundance. The statistical significance 
level was determined as p < 0.05.
Bacterial Cultivation and Interaction Assays. An agar diffusion test (Kirby–Bauer method) was 
employed to determine in-vitro interaction between bacterial strains. The bacterial strains were selected based 
on metagenomic and clinical data. In a separate group of patients (10 healthy control subjects, 10 CRSwNP−A 
patients, and 10 CRSwNP+A patients) we found that the majority of S. aureus strains isolated from CRSwNP 
patients expressed accessory gene regulator (agr) group I and agr group II. Reference strains expressing agr group 
I and II were therefore used in this assay. Staphylococcus aureus (gfp RN6390 and ATCC 29213), Escherichia 
coli (O157:H7 strain), Haemophilus influenzae (ATCC 49144), Corynebacterium pseudodiphtheriticum (CIP 
103420T), and Propionibacterium acnes (ATCC 6919) were selected for the experiment. Chocolate agar plate 
inoculation and incubation at 37 °C with 5% CO2 was determined to be the culture condition that enabled pro-
ficient growth of all bacterial strains. Bacterial colonies were harvested, resuspended in 0.9% NaCl to a turbidity 
that was adjusted to a 0.5 McFarland standard. To test for evidence of cooperative or competitive interaction of 
bacteria, twelve culture plates were used, of which six were smeared uniformly with 0.5 McFarland suspensions 
of each of the six test strains to obtain confluent growth (inoculated plate) and the other six were not inoculated 
(control plates). After left to dry for 5 minutes, 10 µl of 0.5 McFarland standard suspensions of all six test strains 
were spotted on all culture plates. Agar plates were inspected at day 1, 2, 3, 5 and 7 for bacterial growth on the 
spots and also around the spots for the inoculated plates. The amount of growth of the spotted strains on the 
inoculated plates was compared to that on the control plates. Criteria for interpretation were established based on 
ecological interactions27,28. The nine possible interpretations of the interactions, ranging from mutually beneficial 
through neutral to spiteful interactions, are outlined in Table S1.
Results
Characteristics of The Patients. Fifty-eight adults [17 control subjects, 21 CRSwNP patients without 
asthma (CRSwNP−A), and 20 CRSwNP patients with co-morbid asthma (CRSwNP+A)] were enrolled in the 
study. Table 1 illustrates clinical characteristics of the participants. No significant differences with regard to age 
or gender were found among the three groups. Atopic status and aspirin intolerance were significantly more 
prevalent in the CRSwNP+A group, as expected. According to severity of disease based on visual analogue scales 
for symptoms (VAS), CRSwNP+A patients had remarkably more trouble with nasal congestion and mucus than 
CRSwNP−A patients (Fig. 1).
Cytokine Patterns in The Nasal Tissue Samples. Nasal polyp (NP) disease in European patients 
is mostly characterized by an infiltration of eosinophils and expression of high concentrations of ECP. In this 
study, Th2 related mediators and cytokines (IgE, SE-IgE and IL-5) were significantly increased in NP from asth-
matic patients compared with non-asthmatic subjects, as shown in Fig. 2. For example, median total IgE in the 
CRSwNP−A group was 440.4 kU/L (interquartile ranges IQRs: 101–742.5) compared to 1543 kU/L (IQRs: 640–
2321) in the CRSwNP+A group (Table S2). The level of ECP, TNFα, and IL-17 showed no significant differences 
between groups. Furthermore, the SE-IgE positive group showed notable higher concentrations of IgE (median in 
the SE-Ig E positive subjects 1307 kU/L vs. 252 kU/L in SE-Ig E negative subjects, p < 0.0001), IL-5 (701 pg/mL vs. 
77 pg/mL, p < 0.01), and ECP (29920 μg/L vs. 14045 μg/L, p < 0.01) when compared to the SE-IgE negative group.
Microbial Diversity and Relative Abundances of Bacterial Species. Bacterial DNA was detected 
in all samples. The number of phylotypes varied from 26 to 207 per sample with an average of 113 phylotypes 
in the control group, 116 phylotypes in the CRSwNP−A group, and 109 phylotypes in the CRSwNP+A group. 
Regarding the total number of reads of 16S rRNA gene, there was no statistically significant difference among 
the three groups, indicating that control subjects and CRSwNP patients had about the same total bacterial load. 
However, the sinonasal microbiota of CRSwNP as a group, regardless of co-morbid asthma, showed significantly 
decreased bacterial diversity (Shannon H index) and evenness (Pielou’s evenness index), when compared with 
the control group. Especially, the CRSwNP−A group exhibited significantly reduced bacterial evenness and 
Control CRSwNP−A CRSwNP+A
Statistical 
analysis*
Number of subjects 17 21 20
Mean age (yr) 44.94 47.52 45.75 p = 0.8688
Male/Female 9/8 10/11 12/8 p = 0.7285
Atopy status positive (%) 0 19 80 p < 0.0001
Aspirin intolerance (%) 0 0 33.33 p = 0.0014
Table 1. Characteristics of control and patient groups. *Statistical test used. Kruskal-Wallis test for Age.  
Chi-square test for Gender, Atopy status, and Aspirin intolerance.
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Shannon’s diversity when compared with the control group. No significant differences were found with regard to 
Chao-1 species richness indexes in intergroup comparisons (Fig. 3).
The phylum-level structure of our samples is depicted on Fig. 4. With respect to health and disease status, 
Phylum Proteobacteria and genus Haemophilus were more abundance in CRSwNP disease than healthy control, 
while the average abundances of phylum Actinobacteria, Bacteroidetes, and genus Bacteroides were dominant in 
healthy control subjects when compared with CRSwNP cases. At the species level, Haemophilus influenzae was 
significantly more abundant in CRSwNP patients than in control subjects. Corynebacterium pseudodiphtheriticum 
Figure 1. Visual analogue scale. The figure shows the symptom profile and symptom severity of the two patient 
groups. Nasal congestion and mucus scales were significantly higher in asthmatic patients compared to non-
asthmatic patients. Statistical analysis was performed using Mann-Whitney test. *p < 0.05; **0.001 < p < 0.01.
Figure 2. Cytokine expression in nasal tissues. The graphs show median, upper and lower quartiles. High IgE, 
SE-IgE and IL-5 concentrations characterize the inflammation in NP from asthmatic patients. Statistic results 
were calculated using the t-test for Gaussian-distributed data and the Mann-Whitney test for non-normal 
distribution. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
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was more prevalent in diseases when compared with controls. Staphylococcus xylosus and Bifidobacterium longum 
were more prevalent and abundant in the control group than in the CRSwNP group (Fig. 5a).
A principal coordinate analysis (PCoA) ordination depicted sinus bacterial beta diversity between samples 
(Fig. S1). One-way PERMANOVA with Bray-Curtis index detected statistically significant differences of bacterial 
communities in intergroup comparisons (Holm-Bonferroni sequential corrected p-values < 0.001). A post-hoc 
pairwise comparison revealed differences in microbial composition between control and CRSwNP+A groups 
(p < 0.01), control and CRSwNP−A groups (p < 0.01), and between CRSwNP patients (p < 0.03).
Considering the bacterial composition at the phylum level (Fig. 6), Proteobacteria predominated in 
CRSwNP+A group compared with CRSwNP−A and control group, whereas Actinobacteria were more abun-
dant in the control subjects than in patients with CRSwNP+A. The average abundances of Bacteroidetes were 
notably higher in control subjects when compared with CRSwNP−A patients. At the genus levels, CRSwNP−A 
Figure 3. Biodiversity indices. The graphs compare diversity indices (Shannon diversity, richness, 
and evenness) between control subjects and patients with CRSwNP−A and CRSwNP+A. Statistical 
analysis was performed using Kruskal-Wallis and Dunn’s multiple comparisons test. **0.001 < p < 0.01; 
***0.0001 < p < 0.001.
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patients carried significantly higher abundance of Corynebacterium (p = 0.04) genera (phylum Actinobacteria) 
and Geobacter (p < 0.01) genera (phylum Proteobacteria) when compared with CRSwNP+A patients (Fig. S2).
At the species level (Fig. 7), Moraxella catarrhalis was more prevalent and abundant in CRSwNP+A subjects, 
compared to CRSwNP−A subjects, whereas a relative abundance of Geobacter anodireducens/sulfurrreducens 
and Pelomonas puraquae was noted in CRSwNP−A subjects. All aforementioned species are member of the 
phylum Proteobacteria. The prevalence of Moraxella catarrhalis, Staphylococcus aureus and Staphylococcus xylo-
sus was significantly lower in CRSwNP−A group when compared with the other groups (p < 0.05). The mean 
relative abundance of Staphylococcus xylosus was also notably lower in CRSwNP−A group when compared 
with the other groups. The prevalence and relative abundance of Bifidobacterium longum was higher in healthy 
group than CRSwNP−A group. For example, Staphylococcus aureus was prevalent in 94% of healthy control 
subjects, 57% of CRSwNP−A patients, and 90% of CRSwNP+A patients. The average relative abundance of 
Staphylococcus aureus was 185 in the healthy group, 654 in the CRSwNP−A group, and 145 in the CRSwNP+A 
group (Fig. S3). Propionibacterium acnes (phylum Actinobacteria) was the most abundant species in the con-
trol group, Staphylococcus aureus (phylum Firmicutes) in the CRSwNP−A group and Escherichia coli (phylum 
Proteobacteria) in the CRSwNP+A group.
Correlations between Cytokine Levels and Relative Abundance of Bacteria. Comparison of 
cytokine levels with relative abundance of bacteria in the nasal polyps tissues revealed that ECP and IL-5 were 
negatively correlated with the phylum Actinobacteria (p < 0.05, r = −0.3652, and −0.3760 respectively). The 
phylum Bacteroidetes correlated positively with IL-5 (p < 0.02, r = 0.3969), but negatively with IL-17 (p < 0.01, 
r = −0.4632).
At the species level, total IgE and IL-5 were negatively correlated with Geobacter anodireducens/sulfurreducens 
and Pelomonas puraquae, IL-5 was negatively correlated with Corynebacterium macginleyi, and ECP was nega-
tively correlated with Corynebacterium accolens, C. macginleyi and Streptococcus pneumoniae. In contrast, ECP 
and IL-5 were positively correlated with E. coli. Staphylococcus aureus and Propionibacterium acnes were not cor-
related with any cytokine. IL-17 and TNF-α were not correlated with any of the top 20 bacterial species (Table S3). 
However, no single correlation reached a correlation coefficient of higher than 0.6 (moderate correlation).
Interspecies Interactions of Cultured Bacterial Species. When testing the possible interactions 
between six strains of five of the most frequently present species, we observed that growth of C. pseudodiptherit-
icum on the inoculated plate was enhanced by the presence of S. aureus RN6390 and H. influenzae, but retarded 
by E. coli and inhibited by S. aureus ATCC 29213. P. acnes appeared to be inhibitied by S. aureus (both strains), E. 
coli and H. influenzae. Furthermore, H. influenzae was inhibited by S. aureus ATCC 29213 and E. coli. Growth of 
S. aureus RN6390 was inhibited by E. coli.
With respect to growth pattern of the strains used to initially inoculate the plates, C. pseudodiptheriticum 
swiftly flourished in the proximity of the E. coli inoculation point, whereas growth of P. acnes was inhibited 
around the inoculation point of S. aureus ATCC 29213. Neither growth inhibition nor growth promotion was 
noticed between C. pseudodiptheriticum and P. acnes, and between S. aureus ATCC 29213 and E. coli. Figure 8 
outlines the observed bacterial growth patterns. Interspecies interplay on the basis of the available information 
from our in-vitro experiments is depicted in Fig. 9.
Figure 4. Bacterial community composition in each subject at the phylum level. C: control subject, P: 
CRSwNP−A subject, A: CRSwNP+A subject.
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Discussion
The nasal bacterial community has been suggested to play a role in the development and severity of CRSwNP dis-
ease29,30. The aim of this study was to establish whether and to what extent there might be differences in the nasal 
Figure 5. Bacterial species that discriminate between groups (a) and among groups (b). The graphs show the 
relative abundance of discriminative species different between groups. Dots represent relative abundance in 
each sample. *p < 0.05, **p < 0.01, and ***p < 0.001.
Figure 6. Phylum-level differences between groups. Dot graphs show relative abundance of bacterial phylafrom 
each sample. Kruskal-Wallis and Dunn’s multiple comparisons were employed for statistical analysis. *p < 0.05; 
**0.001 < p < 0.01.
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microbiota of healthy control subjects, compared to those of non-asthmatic and asthmatic CRSwNP patients. 
Subgrouping of the patients into endotypes was based on our previous studies3,6. Indeed, CRSwNP disease can 
be further classified on the basis of distinct biomarkers (IgE, SE-IgE, and IL-5) that are increased in nasal polyps 
tissue when there is comorbidity (asthma). Different microbiota might represent different functional commu-
nities and invoke an immune response ranging from homeostatic to detrimental inflammatory effects, as such 
explaining the differences between the different endotypes.
Aberrant bacterial community in CRSwNP disease. This study identifies that the relative abundance of 
H. influenzae is remarkably higher in CRSwNP cases compared to normal subjects. Combining the experimental 
data from mice31, the epidemiological data from humans32, and our observation of an association of H. influenzae 
Figure 7. Prevalence and mean relative abundance of the most abundant bacterial species in our study. The heat 
maps in white-to-black and white-to-red depict the prevalence and relative abundance, respectively. The order 
was arranged based on the contribution to the observed dissimilarity. ns: no statistical significance (p ≥ 0.05); 
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
Figure 8. Mutual inhibition and growth promotion between different bacterial species that are most abundant 
in controls and patient groups.
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with CRSwNP, we hypothesize that H. influenzae can initiate and drive inflammatory responses to develop nasal 
polyposis and therefore it may be hypothesized that elimination of H. influenzae in an acute phase might reduce 
incidence of NP cases. It might further be assumed that success or failure of the antibiotic treatment of the acute 
phase infection might drive an ongoing inflammation into resolution or NP formation, respectively.
In addition, the bacterial community in CRSwNP+A patients showed dominance of the phylum 
Proteobacteria, caused by unexpectedly high numbers of E. coli (Enterobacteriaceae), although not significantly 
different from the other two groups, whereas S. aureus was predominant in CRSwNP−A patients. Our findings 
concurred with a previous study that reported strong increase of Enterobacteriaceae in bronchial lavage of patients 
with asthma compared to control subjects33. When we combined the data of members of the Proteobacteria (i.e. 
E. coli, H. influenzae, and M. catarrhalis), we could establish a significant increase in relative abundance of these 
bacteria for patients with CRSwNP+A compared to the control group (Fig. 5b).
Proteobacteria might contribute to the pathogenesis of CRSwNP disease via eicosanoids and related media-
tors34. The abundance of E. coli in several CRSwNP+A patients and the positive correlation of E. coli with ECP 
and IL-5 suggest a role of E. coli in severity of type 2 inflammation in CRSwNP patients.
It is possible that E. coli impairs the epithelial barrier and cooperates with putative pathogens for initiation and 
amplification of type 2 inflammation in CRSwNP disease.
Effect of microbial components on putative pathogens. In the current study, the average relative 
abundance of S. aureus in CRSwNP−A patients is higher than that in healthy control subjects, but this is not the 
case for CRSwNP+A patients. The presence of specific IgE to staphylococcal enterotoxins (SE-IgE) is significantly 
more frequent in the CRSwNP+A compared to the CRSwNP−A and control groups and correlates with disease 
severity. This observation supports the role of S. aureus and its immune proteome in the persistence of airway 
disease35,36. Apparently, our findings seem to indicate that the composition of the bacterial community may influ-
ence the S. aureus virulence. The presence of large numbers of Actinobacteria (e.g. Corynebacterium spp.) in the 
environment might shift S. aureus to benign colonization, whereas increased numbers of Proteobacteria (pre-
dominantly E. coli) in the milieu might drive S. aureus to exhibit pathogenic behavior. It may be conceivable that 
bacterial composition and interactions in the community culminate in a functional community that organizes 
commensal-pathogen interchange. Intraspecific variability cannot be ruled, whereby S. aureus strains present in 
healthy samples could differ from strains from samples from diseases patients. In one study, a strain of S. aureus 
inhibited other strains of the same species co-colonizing in nasal cavity37. Various hypotheses were proposed to 
determine the regulation of S. aureus virulence, of which the global control of accessory gene regulator (agr) is the 
most promising one38. We also identified strain-level variations of S. aureus, classified by agr, in an independent 
survey and in-vitro bacterial interaction experiments. S. aureus RN 6390 belonging to agr group I and S. aureus 
ATCC 29213 agr group II. S. aureus agr group I had a positive impact on C. pseudodiptheriticum, whereas S. 
aureus agr group II had a negative impact on C. pseudodiptheriticum. Moreover, S. aureus agr group II killed P. 
acnes in our experiments. A survey of S. aureus agr in higher numbers of patients should be conducted to confirm 
the possible importance of agr diversity of S. aureus in pathogenesis of CRS diseases.
Corynebacterium species have been implicated as competitors with S. aureus in the nasal niche39,40 or as tem-
pering S. aureus virulence41. One research group observed that C. pseudodiphtheriticum was present more often 
in non-S. aureus carriers than that in S. aureus carriers42. This group confirmed a competitive interaction between 
S. aureus and C. pseudodiphtheriticum42, which is not supported by our data. We detected C. pseudodiptherit-
icum more frequently in the CRSwNP status. In addition, our in-vitro interactions rather indicated a positive 
Figure 9. Bacterial in vitro interactions. Red lines represent a negative relationship, green lines represent a 
positive relationship, and black lines represent a neutral relationship. All bacterial pictures are credited to 
Centers for Disease Control and Prevention (CDC). The bacterial pictures were taken from Public Health Image 
Library (https://phil.cdc.gov/phil/home.asp). C. pseudodiptheriticum image ID#: 2126. E. coli image ID#: 10068 
photo credit: Janice Harney Carr H. influenzae image ID#: 1947 P. acnes image ID#: 2122 S. aureus image ID#: 
11157 photo credit: Janice Harney Carr.
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cooperation between C. pseudodiptheriticum and putative pathogens, such as E. coli, H. influenzae and S. aureus 
(agr group I).
Although several studies have described a negative association between S. aureus and S. epidermidis in the 
nasal cavity40,43, our data did not show competition between S. aureus and S. epidermidis.
Bacterial Associations with Inflammation in CRS. A study using only 7 samples from CRS patients 
and a not-validated mice model concluded that Corynebacterium tuberculostearicum was a pathogen of CRS44, 
while another study reported that CRS patients with enriched C. tuberculostearicum colonization in their nose, 
at the time of endoscopic sinus surgery, showed better surgical outcomes10. However, in our study neither a 
beneficial nor pathogenic role of C. tuberculostearicum can be concluded. We found that the distribution and rel-
ative abundance of C. tuberculostearicum was equivalent among groups. We also observed a negative correlation 
between eosinophilic activity in the tissue (i.e., ECP and IL-5) and other members of genus Corynebacterium 
(i.e., C. macginleyi, and C. accolens) that belong to phylum Actinobacteria. According to our previous study, the 
level of IL-5 is one of the prognostic factors in CRSwNP disease14. These results suggest that members of phylum 
Actinobacteria, i.e.,Corynebacterium spp. (e.g. C. macginleyi), are associated with a lower degree of eosinophilic 
inflammation in CRSwNP patients.
Health-associated Microbes. Several bacterial phyla were dominant in healthy individuals. The poten-
tially beneficial microbe in the current study was a member of the phylum Actinobacteria; we found that 
Propionibacterium acnes was the most abundant microorganism in the healthy condition. Normally, P. acnes is a 
commensal microbe of adult human skin45. P. acnes, which prefers a lipid-rich anaerobic environment, has been 
detected in sinonasal cavities of healthy adults9,42,43,46. P. acnes has been described to promote Th1 and Treg cells 
and relieves atopic dermatitis symptoms47, possibly by the production of short-chain fatty acids that are immu-
nomodulating. Moreover, the principal metabolite of P. acnes, propionic acid, not only reduces inflammation by 
effects on macrophages48, but also inhibits S. aureus growth49. This argument nevertheless remained unsupported 
by our pilot study. The levels of propionic acid measured in the sinonasal environment did not reach the mini-
mum inhibitory concentration of S. aureus. Furthermore, P. acnes did not prevent the growth of S. aureus, which 
in turn killed P. acnes to establish its own growth. These data do indicate that P. acnes is an commensal rather than 
a defender, although in-vitro data regarding to bacterial interactions cannot be straightforwardly transposed to 
the in-vivo situation. P. acnes probably possess other factors for its fitness in healthy subjects. Healthy hosts may 
provide nutrients for P. acnes existence. Health-associated microbes should be further investigated to identify a 
genuine probiotic for the treatment of CRS disease.
This study provides a blueprint for identifying important microbial influencers of disease that provide infor-
mation of structure and member of nasal microbiota linked to clinical phenotypes and endotypes such as sub-
groups of CRSwNP disease (Fig. 10). Our findings highlight the need for more functional studies of bacterial 
community to determine the role of microbiota in CRS pathogenesis.
Limitations. Several limitations should be addressed. Although we excluded patients that used steroids sys-
temically, all CRSwNP patients may have taken intranasal steroid until shortly before the biopsy. The effect of 
steroids on bacterial communities remains unclear, although nasal irrigation with budesonide did not change the 
proportional abundance of bacteria in CRSwNP patients50. We were concerned about the specificity of molec-
ular techniques, even though it has been shown that the relative abundance of bacterial DNA had a positive 
correlation with colony-forming unit counts (CFUs)30. Comparing recovered DNA to live colony counting, it 
Figure 10. Characteristics of bacterial communities for the different groups.
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appeared that in diseased subjects, Staphylococcus DNA mostly came from living bacteria, whereas in healthy 
subjects, Staphylococcus DNA was mostly recovered from dead bacteria51. The method used here for microbi-
ota may detect genetic material of non-viable microorganisms that distort the genuine microbial community 
composition. Moreover, one bacterial cell carries from 1 up to 15 copies 16S rRNA gene copies per genome52. 
The analysis of 16S rRNA can provide only the information of bacterial presence, but not metabolically active 
microorganism. The extraction and analysis of metagenomic mRNA (the metatranscriptome) or proteomic or 
metabolomic research should be further performed to assess the functional and metabolic diversity of microbial 
communities. Interplays between bacteria in our experiments are performed under in-vitro conditions. Although 
the tested strains were not directly isolated from the subjects studied, and relevant variations in the metabolites 
of the microbes may occur, the selected strains were chosen based on investigations in the same patient groups 
to best represent the situation in the human nose. We tested the interaction of only two species of bacteria. 
Interactions among the full spectrum of bacteria in-situ conditions may be different. The participation of the 
third, forth, and more species probably affects those bacterial behavior differently. A complementarily ecological 
theory would need to explain overarching interactions and patterns for the microbiota. Future research should 
explore functional parts of bacterial community and their impacts on the nasal mucosa. Investigations of bacterial 
communities and their impacts on sinonasal immune responses may pave the way for a better understanding of 
how the microbiota contribute to the pathogenesis of CRS.
Conclusions
This study identifies a difference in nasal microbiota between healthy subjects and phenotypes of CRSwNP 
patients. Proteobacteria (such as H. influenzae, E.coli, M. catarrhalis) were associated with CRSwNP disease, 
especially with CRSwNP+A cases, whereas Actinobacteria (such as P. acnes, Corynebacterium spp.) were prev-
alent in the healthy status. However, P. acnes, a resident commensal bacterium in healthy subjects, does not play 
the protective role against S. aureus one could expect from its abundance. Furthermore, although S. aureus was 
found abundant in CRSwNP−A, but not in CRSwNP+A, the presence of SE-IgE in the latter group representing 
its immunologic fingerprint rather than S. aureus itself is associated with disease severity. The functions of micro-
biota and their products in health and airway disease should be further elucidated to determine the effective role 
of microbiota in the pathomechanism of CRS disease.
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